GENES & GENETIC SYSTEMS, an esteemed journal published by the Genetics Society of Japan, serves as a vital platform for the dissemination of innovative research within the fields of genetics, molecular biology, and medicine. Established in 1996 and based in Mishima, Shizuoka, Japan, this journal has actively contributed to the academic community, fostering collaboration and knowledge sharing among researchers and professionals. The journal’s impact can be seen through its category quartiles, which reflect its position in Genetics, Molecular Biology, and Medicine, and while it currently ranks in Q4 in Genetics and Q3 in Medicine (miscellaneous), it is poised for growth as it continues to publish pivotal studies. With a commitment to open access, GENES & GENETIC SYSTEMS ensures that research findings are freely accessible to the global scientific community, promoting a more inclusive approach to knowledge distribution. This journal is essential for students, researchers, and professionals seeking to stay informed of advancements in genetic research and its implications for the broader field of medicine.

NATURE REVIEWS GENETICS, published by NATURE PORTFOLIO, stands as a leading journal in the field of genetics, boasting a remarkable reputation reflected in its Q1 ranking across multiple categories including Genetics, Clinical Genetics, and Molecular Biology. With an impressive percentile of 99th in both Genetics and Clinical Genetics, as well as a solid rank in Molecular Biology, this journal is pivotal for researchers, professionals, and students alike who seek to stay informed on the latest advancements and comprehensive reviews in genetic research. The journal's scope encompasses a wide array of topics, providing in-depth insights from fundamental genetic principles to clinical applications, underscoring its importance in bridging basic science and medical practice. Though not an open-access publication, it remains accessible through various academic institutions, enhancing its reach and influence within the scientific community. With publication years spanning from 2000 to 2024, NATURE REVIEWS GENETICS continues to shape the future of genetics research and education.

MOLECULAR GENETICS AND GENOMICS is a distinguished journal published by SPRINGER HEIDELBERG that serves as a pivotal platform for the communication of cutting-edge research and developments in the fields of genetics, molecular biology, and medicine. With an ISSN of 1617-4615 and an E-ISSN of 1617-4623, this journal has established itself since its inception in 1994 as a significant resource for researchers aiming to explore the complexities of genetic interactions and their implications in various biological systems. The journal is indexed in Scopus, with respectable rankings in the Genetics, Molecular Biology, and Biochemistry categories, showcasing its position within the academic community. It is categorized in the 2023 rankings as Q3 in Genetics, Q2 in Medicine (miscellaneous), and Q3 in Molecular Biology, indicating its relevance and quality in the scientific discourse. The journal also promotes open access, ensuring that researchers and professionals can easily share and advance knowledge in the rapidly evolving disciplines of molecular genetics and genomics. As the journal continues to bridge the gap between experimental and theoretical research, it presents a vital space for innovation, fostering collaborations and scholarly exchange among its readership.

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

NUCLEUS-INDIA is a prominent academic journal that delves into the intricate realms of Cell Biology, Genetics, Molecular Biology, and Molecular Medicine. Published by SPRINGER INDIA, this journal has been a reliable source of innovative research since its inception in 2011. With an ISSN of 0029-568X and an E-ISSN of 0976-7975, NUCLEUS-INDIA stands out in the scientific community, functioning as a critical platform for the dissemination of groundbreaking findings and advancements within its fields of study. Despite being categorized in the lower quartiles as of 2023, it remains an important contributor to the literature, providing insights that influence both academic and practical perspectives in genetics and molecular sciences. Researchers, professionals, and students alike can benefit from its diverse array of articles addressing contemporary challenges and innovations. The journal is located at 7th Floor, Vijaya Building, 17, Barakhamba Road, New Delhi 110 001, India, and aims to enhance the scholarly discourse in biology by publishing works that push the boundaries of current understanding.

Genes is a leading open-access journal published by MDPI that focuses on advancing the field of genetics and genomics. Established in 2010 and based in Basel, Switzerland, this journal has made significant strides in promoting innovative research in both clinical genetics and molecular biology. With an impact factor reflecting its relevance and quality, Genes has been classified in the Q2 quartile for Genetics and the Q3 quartile for clinical Genetics as of 2023. The journal provides an accessible platform for researchers, professionals, and students to disseminate their findings and explore emerging trends across the genetics landscape. Accessible online since its inception, Genes allows for continuous engagement and collaboration within the scientific community, fostering a deeper understanding of genetic mechanisms and their implications in health and disease.

Genes & Genomics is a prominent academic journal dedicated to the fields of biochemistry, genetics, and molecular biology, published by Springer from South Korea. With an evolving focus on innovative genetic research and its implications, this journal serves as a crucial platform for disseminating knowledge within the scientific community. The journal has been indexed in Scopus and boasts a Q3 quartile ranking in 2023 for its contributions to these disciplines, highlighting its relevance and growing impact. In addition to traditional subscription options, Genes & Genomics supports Open Access, offering broader accessibility for researchers and enthusiasts eager to explore the latest advancements in genetic studies. Since its inception in 2008, the journal has committed to publishing high-quality research that drives forward our understanding of genetics and its applications, making it an essential resource for researchers, professionals, and students alike who are passionate about the complexities and breakthroughs in genomic sciences.

MUTATION RESEARCH - FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS is a premier peer-reviewed journal published by Elsevier, dedicated to advancing the understanding of mutagenesis and its broader implications in genetics, health, and molecular biology. With an impressive converged publication history from 1964 to 2024, this journal provides a vital platform for the dissemination of high-quality research findings, contributing significantly to the field's knowledge base. Indexed in Scopus, it holds a Category Quartile ranking of Q3 in Genetics and Q2 in Health, Toxicology, and Mutagenesis, further underscoring its relevance and stature. Access options are available, catering to a diverse audience of researchers, professionals, and students eager to stay informed on the latest developments in mutagenesis research. By bridging experimental studies and theoretical frameworks, the journal plays a crucial role in exploring the fundamental mechanisms underlying genetic mutations and their effects on human health and the environment.

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

HUMAN MOLECULAR GENETICS, published by Oxford University Press, is a premier journal in the field of genetics, with an established reputation since its inception in 1992. With an impressive Q1 ranking in various categories, including Genetics, Clinical Genetics, and Molecular Biology, this journal engages a diverse readership by reporting significant advances in our understanding of the genetic basis of human health and disease. The journal has achieved notable rankings within Scopus, particularly in Clinical Genetics, making it a key resource for professionals and researchers aiming to stay at the forefront of genetic research. Although it operates under a traditional access model, it remains committed to disseminating high-quality research that informs clinical practice and enhances knowledge in the genetic field. The journal's impact factor signifies its crucial role in shaping contemporary genetic research and its application in medicine. As the field continues to evolve, HUMAN MOLECULAR GENETICS serves not only as an academic repository but also as a vital platform for innovation and discussion among students, researchers, and clinicians.